VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1Study of Apraglutide in Japan
| VECTDelisted Stock | USD 16.85 0.00 0.00% |
Slightly above 56% of VectivBio Holding's investor base is looking to short. The analysis of current outlook of investing in VectivBio Holding AG suggests that many traders are alarmed regarding VectivBio Holding's prospects. VectivBio Holding's investing sentiment can be driven by a variety of factors including economic data, VectivBio Holding's earnings reports, geopolitical events, and overall market trends.
VectivBio |
Single-dose study to assess pharmacokinetics, pharmacological activity, safety and tolerability in healthy Japanese men and womenBASEL, Switzerland, March 13, 2023 -- VectivBio Holding AG , a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, and Asahi Kasei Pharma Corporation today announced the start of a Phase 1 study investigating the pharmacokinetics, pharmacolo
Read at finance.yahoo.com
 |
VectivBio Holding Fundamental Analysis
We analyze VectivBio Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VectivBio Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VectivBio Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
VectivBio Holding is currently under evaluation in target price category among its peers.
VectivBio Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VectivBio Holding stock to make a market-neutral strategy. Peer analysis of VectivBio Holding could also be used in its relative valuation, which is a method of valuing VectivBio Holding by comparing valuation metrics with similar companies.
Peers
VectivBio Holding Related Equities
| ENVB | Enveric Biosciences | 12.90 | ||||
| CNSP | Cns Pharmaceuticals | 10.00 | ||||
| IMMX | Immix Biopharma | 6.67 | ||||
| ELEV | Elevation Oncology | 5.36 | ||||
| OCEA | Ocean Biomedical | 1.79 | ||||
| ZURA | Zura Bio | 6.37 | ||||
| ZVSA | ZyVersa Therapeutics | 6.50 | ||||
| HEPA | Hepion Pharmaceuticals | 8.00 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in VectivBio Stock
If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance |